CLYM
Price
$10.44
Change
-$0.76 (-6.79%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
675.7M
76 days until earnings call
Intraday BUY SELL Signals
KYTX
Price
$7.81
Change
-$0.09 (-1.14%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
499.74M
76 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CLYM vs KYTX

Header iconCLYM vs KYTX Comparison
Open Charts CLYM vs KYTXBanner chart's image
CLYM vs KYTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CLYM vs. KYTX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLYM is a Hold and KYTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2026
Stock price -- (CLYM: $11.20 vs. KYTX: $7.89)
Brand notoriety: CLYM and KYTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLYM: 168% vs. KYTX: 154%
Market capitalization -- CLYM: $675.7M vs. KYTX: $499.74M
CLYM [@Biotechnology] is valued at $675.7M. KYTX’s [@Biotechnology] market capitalization is $499.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.89B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLYM’s FA Score shows that 0 FA rating(s) are green whileKYTX’s FA Score has 0 green FA rating(s).

  • CLYM’s FA Score: 0 green, 5 red.
  • KYTX’s FA Score: 0 green, 5 red.
According to our system of comparison, CLYM is a better buy in the long-term than KYTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLYM’s TA Score shows that 3 TA indicator(s) are bullish while KYTX’s TA Score has 3 bullish TA indicator(s).

  • CLYM’s TA Score: 3 bullish, 5 bearish.
  • KYTX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CLYM is a better buy in the short-term than KYTX.

Price Growth

CLYM (@Biotechnology) experienced а -1.67% price change this week, while KYTX (@Biotechnology) price change was -8.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.54%. For the same industry, the average monthly price growth was -1.96%, and the average quarterly price growth was +3.26%.

Reported Earning Dates

CLYM is expected to report earnings on Aug 18, 2026.

KYTX is expected to report earnings on Aug 18, 2026.

Industries' Descriptions

@Biotechnology (-1.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLYM($676M) has a higher market cap than KYTX($500M). CLYM YTD gains are higher at: 180.000 vs. KYTX (-16.064). CLYM has higher annual earnings (EBITDA): -59.94M vs. KYTX (-158.93M). KYTX has more cash in the bank: 171M vs. CLYM (110M). CLYM has less debt than KYTX: CLYM (479K) vs KYTX (5.02M). CLYM (0) and KYTX (0) have equivalent revenues.
CLYMKYTXCLYM / KYTX
Capitalization676M500M135%
EBITDA-59.94M-158.93M38%
Gain YTD180.000-16.064-1,121%
P/E RatioN/AN/A-
Revenue00-
Total Cash110M171M64%
Total Debt479K5.02M10%
TECHNICAL ANALYSIS
Technical Analysis
CLYMKYTX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 24 days ago
90%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CLYM
Daily Signal:
Gain/Loss:
KYTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IRLUX51.92N/A
N/A
Voya Russell Large Cap Index Port S2
RPTIX99.99N/A
N/A
T. Rowe Price Mid-Cap Growth I
SGRHX45.59N/A
N/A
Allspring Growth R6
TGWFX12.20N/A
N/A
Transamerica Large Growth R4
MADRX25.86N/A
N/A
Madison Dividend Income R6

CLYM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLYM has been loosely correlated with KYTX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CLYM jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLYM
1D Price
Change %
CLYM100%
-5.08%
KYTX - CLYM
41%
Loosely correlated
-4.01%
ALGS - CLYM
36%
Loosely correlated
-3.36%
IMVT - CLYM
36%
Loosely correlated
-5.90%
IMNM - CLYM
33%
Loosely correlated
-7.03%
ZNTL - CLYM
33%
Loosely correlated
-0.75%
More

KYTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYTX has been loosely correlated with FDMT. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if KYTX jumps, then FDMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYTX
1D Price
Change %
KYTX100%
-4.01%
FDMT - KYTX
47%
Loosely correlated
-4.53%
IMNM - KYTX
45%
Loosely correlated
-7.03%
VTGN - KYTX
44%
Loosely correlated
-10.42%
VYGR - KYTX
44%
Loosely correlated
-5.15%
XNCR - KYTX
44%
Loosely correlated
-5.00%
More